Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development
View ORCID ProfileOleksii Nikolaienko, Hans P. Eikesdal, View ORCID ProfileBjørnar Gilje, Steinar Lundgren, Egil S. Blix, Helge Espelid, Jürgen Geisler, Stephanie Geisler, View ORCID ProfileEmiel A.M. Janssen, View ORCID ProfileSynnøve Yndestad, Laura Minsaas, Beryl Leirvaag, Reidun Lillestøl, View ORCID ProfileStian Knappskog, Per E. Lønning
doi: https://doi.org/10.1101/2023.05.14.23289949
Oleksii Nikolaienko
1K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen; Bergen, Norway
2Department of Oncology, Haukeland University Hospital; Bergen, Norway
Hans P. Eikesdal
1K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen; Bergen, Norway
2Department of Oncology, Haukeland University Hospital; Bergen, Norway
Bjørnar Gilje
3Department of Hematology and Oncology, Stavanger University Hospital; Stavanger, Norway
Steinar Lundgren
4Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital; Trondheim, Norway
5Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology; Trondheim, Norway
Egil S. Blix
6Department of Oncology, University Hospital of North Norway; Tromsø, Norway
Helge Espelid
7Department of Surgery, Haugesund Hospital; Haugesund, Norway.
Jürgen Geisler
8Department of Oncology, Akershus University Hospital; Lørenskog, Norway.
9Institute of Clinical Medicine, University of Oslo, Norway
Stephanie Geisler
8Department of Oncology, Akershus University Hospital; Lørenskog, Norway.
Emiel A.M. Janssen
10Department of Pathology, Stavanger University Hospital; Stavanger, Norway
11Department of Chemistry, Bioscience and Environmental Engineering; Stavanger University, Stavanger, Norway
Synnøve Yndestad
1K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen; Bergen, Norway
2Department of Oncology, Haukeland University Hospital; Bergen, Norway
Laura Minsaas
1K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen; Bergen, Norway
2Department of Oncology, Haukeland University Hospital; Bergen, Norway
Beryl Leirvaag
1K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen; Bergen, Norway
2Department of Oncology, Haukeland University Hospital; Bergen, Norway
Reidun Lillestøl
1K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen; Bergen, Norway
2Department of Oncology, Haukeland University Hospital; Bergen, Norway
Stian Knappskog
1K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen; Bergen, Norway
2Department of Oncology, Haukeland University Hospital; Bergen, Norway
Per E. Lønning
1K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen; Bergen, Norway
2Department of Oncology, Haukeland University Hospital; Bergen, Norway
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted May 16, 2023.
Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development
Oleksii Nikolaienko, Hans P. Eikesdal, Bjørnar Gilje, Steinar Lundgren, Egil S. Blix, Helge Espelid, Jürgen Geisler, Stephanie Geisler, Emiel A.M. Janssen, Synnøve Yndestad, Laura Minsaas, Beryl Leirvaag, Reidun Lillestøl, Stian Knappskog, Per E. Lønning
medRxiv 2023.05.14.23289949; doi: https://doi.org/10.1101/2023.05.14.23289949
Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development
Oleksii Nikolaienko, Hans P. Eikesdal, Bjørnar Gilje, Steinar Lundgren, Egil S. Blix, Helge Espelid, Jürgen Geisler, Stephanie Geisler, Emiel A.M. Janssen, Synnøve Yndestad, Laura Minsaas, Beryl Leirvaag, Reidun Lillestøl, Stian Knappskog, Per E. Lønning
medRxiv 2023.05.14.23289949; doi: https://doi.org/10.1101/2023.05.14.23289949
Subject Area
Subject Areas
- Addiction Medicine (330)
- Allergy and Immunology (652)
- Anesthesia (174)
- Cardiovascular Medicine (2522)
- Dermatology (211)
- Emergency Medicine (386)
- Epidemiology (12002)
- Forensic Medicine (10)
- Gastroenterology (721)
- Genetic and Genomic Medicine (3915)
- Geriatric Medicine (367)
- Health Economics (655)
- Health Informatics (2531)
- Health Policy (975)
- Hematology (352)
- HIV/AIDS (814)
- Medical Education (390)
- Medical Ethics (106)
- Nephrology (420)
- Neurology (3677)
- Nursing (205)
- Nutrition (548)
- Oncology (1911)
- Ophthalmology (557)
- Orthopedics (231)
- Otolaryngology (299)
- Pain Medicine (244)
- Palliative Medicine (71)
- Pathology (466)
- Pediatrics (1077)
- Primary Care Research (436)
- Public and Global Health (6354)
- Radiology and Imaging (1342)
- Respiratory Medicine (847)
- Rheumatology (389)
- Sports Medicine (335)
- Surgery (426)
- Toxicology (51)
- Transplantation (180)
- Urology (156)